tosyllysine chloromethyl ketone has been researched along with benzyloxycarbonylleucyl-leucyl-leucine aldehyde in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Corbett, JA; Hauser, S; Hill, JR; Kwon, G; McDaniel, ML; Turk, J | 1 |
| Weber, C; Weber, KS; Zernecke, A | 1 |
| Fujimuro, M; Hosokawa, K; Ishimaru, H; Sugimoto, A; Tanaka, R; Watanabe, T | 1 |
3 other study(ies) available for tosyllysine chloromethyl ketone and benzyloxycarbonylleucyl-leucyl-leucine aldehyde
| Article | Year |
|---|---|
Evidence for involvement of the proteasome complex (26S) and NFkappaB in IL-1beta-induced nitric oxide and prostaglandin production by rat islets and RINm5F cells.
Topics: Animals; Cell Line, Transformed; Cyclooxygenase 2; Cysteine Proteinase Inhibitors; Dinoprostone; Enzyme Induction; Gene Expression Regulation, Enzymologic; Humans; In Vitro Techniques; Interleukin-1; Islets of Langerhans; Isoenzymes; Leupeptins; Male; Membrane Proteins; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Peptide Hydrolases; Phosphorylation; Prostaglandin-Endoperoxide Synthases; Proteasome Endopeptidase Complex; Rats; Rats, Sprague-Dawley; RNA, Messenger; Signal Transduction; Tosyllysine Chloromethyl Ketone; Tumor Cells, Cultured | 1998 |
Combined modulation of the mesangial machinery for monocyte recruitment by inhibition of NF-kappaB.
Topics: Adenoviridae; Cell Movement; Cells, Cultured; Chemokines; Cysteine Proteinase Inhibitors; DNA-Binding Proteins; Flow Cytometry; Glomerular Mesangium; Humans; I-kappa B Proteins; Immunohistochemistry; Inflammation; Intercellular Adhesion Molecule-1; Leupeptins; Monocytes; NF-kappa B; NF-KappaB Inhibitor alpha; Serine Proteinase Inhibitors; Tosyllysine Chloromethyl Ketone; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2001 |
MG132 exerts anti-viral activity against HSV-1 by overcoming virus-mediated suppression of the ERK signaling pathway.
Topics: Animals; Antiviral Agents; Bortezomib; Caspases; Chlorocebus aethiops; DNA Replication; Enzyme Activation; Gene Expression Regulation, Viral; Hep G2 Cells; Herpesvirus 1, Human; Humans; Leucine; Leupeptins; MAP Kinase Signaling System; Models, Biological; NF-kappa B; NF-KappaB Inhibitor alpha; Phosphorylation; Polyubiquitin; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Stability; Proteolysis; Tosyllysine Chloromethyl Ketone; Tosylphenylalanyl Chloromethyl Ketone; Vero Cells; Virus Replication | 2020 |